Treatment is a minimum of six months where combination tablets are taken. It is sad to note that 25% of those who are started ...
Patients with hidradenitis suppurativa are more likely to develop cardiovascular disease, according to the largest study ...
BE HEARD I and BE HEARD II are the first Phase 3 trials to evaluate the efficacy and safety of an IL-17A and IL–17F inhibitor, BIMZELX ® (bimekizumab-bkzx), in the treatment ...
Førsvoll and Oymar 5 Increased IL-1 β, IL-6, TNF-α levels Inflammation Stojanov et al 9 Increased IL-6, INF-γ, IL-1β, TNF-α levels; reduced IL-4 levels Inflammation Brown et al 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback